Eupnoos

EHere’s a polished **LinkedIn company overview** that integrates the **cancer drug safety** positioning while keeping it crisp, credible, and Ltd** Eupnoos is a health-tech company developing AI-powered digital tools for **cardiorespiratory health and drug safety monitoring**. Our proprietary **audio-phenotyping platform** transforms any smartphone into a clinically-validated device that can analyse breath sounds in seconds to detect signs of **airway obstruction, restriction, or pulmonary congestion**. Beyond respiratory disease detection, Eupnoos is pioneering the use of acoustic biomarkers to **monitor cardiopulmonary adverse events in cancer therapy** — helping clinicians and pharma partners identify early signs of **drug-induced lung injury (DIILD), pneumonitis, or heart failure** before they become severe. Our mission is to make advanced respiratory and safety monitoring **affordable, accessible, and continuous** — empowering patients and healthcare providers to detect problems early, improve outcomes, and reduce avoidable hospitalisations.